OCT 12, 2026 · JOURNAL ARTICLE
Real-World Effects of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Gout Outcomes and Metabolic Profiles
Ibnosina Journal of Medicine and Biomedical Sciences
Abstract Gout is closely linked to metabolic disorders such as obesity, diabetes, and chronic kidney disease. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-gluco